{"id":"https://openalex.org/W4210967684","doi":"https://doi.org/10.1107/s0108767321090814","title":"Neutron crystallography for drug design targeting SARS-CoV-2 viral proteins","display_name":"Neutron crystallography for drug design targeting SARS-CoV-2 viral proteins","publication_year":2021,"publication_date":"2021-08-14","ids":{"openalex":"https://openalex.org/W4210967684","doi":"https://doi.org/10.1107/s0108767321090814"},"language":"en","primary_location":{"id":"doi:10.1107/s0108767321090814","doi":"https://doi.org/10.1107/s0108767321090814","is_oa":false,"landing_page_url":"https://doi.org/10.1107/s0108767321090814","pdf_url":null,"source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089578194","display_name":"Andrey Y. Kovalevsky","orcid":"https://orcid.org/0000-0003-4459-9142","observed_orcids":["https://orcid.org/0000-0003-4459-9142"]},"institutions":[{"id":"https://openalex.org/I1289243028","display_name":"Oak Ridge National Laboratory","ror":"https://ror.org/01qz5mb56","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289243028","https://openalex.org/I1330989302","https://openalex.org/I39565521","https://openalex.org/I4210159294"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrey Kovalevsky","raw_affiliation_strings":["Neutron Scattering Division, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neutron Scattering Division, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA,","institution_ids":["https://openalex.org/I1289243028"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086788899","display_name":"Daniel W. Kneller","orcid":"https://orcid.org/0000-0002-5416-5789","observed_orcids":["https://orcid.org/0000-0002-5416-5789"]},"institutions":[{"id":"https://openalex.org/I1289243028","display_name":"Oak Ridge National Laboratory","ror":"https://ror.org/01qz5mb56","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289243028","https://openalex.org/I1330989302","https://openalex.org/I39565521","https://openalex.org/I4210159294"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Kneller","raw_affiliation_strings":["Neutron Scattering Division, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neutron Scattering Division, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA,","institution_ids":["https://openalex.org/I1289243028"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015921759","display_name":"Leighton Coates","orcid":"https://orcid.org/0000-0003-2342-049X","observed_orcids":["https://orcid.org/0000-0003-2342-049X"]},"institutions":[{"id":"https://openalex.org/I1289243028","display_name":"Oak Ridge National Laboratory","ror":"https://ror.org/01qz5mb56","country_code":"US","type":"facility","lineage":["https://openalex.org/I1289243028","https://openalex.org/I1330989302","https://openalex.org/I39565521","https://openalex.org/I4210159294"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leighton Coates","raw_affiliation_strings":["Second Target Station, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Target Station, Oak Ridge National Laboratory, Oka Ridge, TN 37830, USA","institution_ids":["https://openalex.org/I1289243028"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089578194"],"corresponding_institution_ids":["https://openalex.org/I1289243028"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.14499006,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"a2","first_page":"C613","last_page":"C613"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.8568999767303467,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11162","display_name":"Enzyme Structure and Function","score":0.8568999767303467,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.10980000346899033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11949","display_name":"Nuclear Physics and Applications","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9350000023841858},{"id":"https://openalex.org/keywords/main-protease","display_name":"main protease","score":0.8629999756813049},{"id":"https://openalex.org/keywords/neutron-crystallography","display_name":"neutron crystallography","score":0.7910000085830688},{"id":"https://openalex.org/keywords/protonation-states","display_name":"protonation states","score":0.9509999752044678},{"id":"https://openalex.org/keywords/catalytic-cysteine","display_name":"catalytic cysteine","score":0.8180000185966492},{"id":"https://openalex.org/keywords/zwitterionic-state","display_name":"zwitterionic state","score":0.7059999704360962},{"id":"https://openalex.org/keywords/non-covalent-inhibitors","display_name":"non-covalent inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/virtual-screening","display_name":"virtual screening","score":0.6349999904632568},{"id":"https://openalex.org/keywords/covid-19-antiviral-drug-design","display_name":"COVID-19 antiviral drug design","score":0.8289999961853027}],"concepts":[{"id":"https://openalex.org/C30095370","wikidata":"https://www.wikidata.org/wiki/Q899488","display_name":"Protonation","level":3,"score":0.7637163400650024},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6541712284088135},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.6023930907249451},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4453495442867279},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.4384695887565613},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.4344554543495178},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3831937909126282},{"id":"https://openalex.org/C8010536","wikidata":"https://www.wikidata.org/wiki/Q160398","display_name":"Crystallography","level":1,"score":0.36867380142211914},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25890326499938965},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19034558534622192},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C145148216","wikidata":"https://www.wikidata.org/wiki/Q36496","display_name":"Ion","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1107/s0108767321090814","doi":"https://doi.org/10.1107/s0108767321090814","is_oa":false,"landing_page_url":"https://doi.org/10.1107/s0108767321090814","pdf_url":null,"source":{"id":"https://openalex.org/S4393918093","display_name":"Acta Crystallographica Section A Foundations and Advances","issn_l":"2053-2733","issn":["2053-2733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","medline","norway-1","poland-200","russia-white-list-2"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Crystallographica Section A Foundations and Advances","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4295955712","https://openalex.org/W3209087821","https://openalex.org/W3089296702","https://openalex.org/W3093152392","https://openalex.org/W3089280548","https://openalex.org/W3137172923","https://openalex.org/W3119786628","https://openalex.org/W7203464970","https://openalex.org/W4206386477","https://openalex.org/W3021411957"],"abstract_inverted_index":{"COVID-19,":[0],"caused":[1],"by":[2,60],"SARS-CoV-2,":[3],"is":[4,17,24,58,230,240],"a":[5,160,222],"global":[6],"health":[7],"and":[8,22,31,63,131,143,181,247,258],"economic":[9],"catastrophe.The":[10],"viral":[11],"main":[12],"protease":[13,136],"(M":[14],"pro":[15,111,146,207,237,251],")":[16],"indispensable":[18],"for":[19,28,73,103,163,244,260],"SARS-CoV-2":[20],"replication":[21],"thus":[23],"an":[25,82],"important":[26],"target":[27,43],"small-molecule":[29],"antivirals.Computer-assisted":[30],"structure-guided":[32],"drug":[33,104],"design":[34,234,246],"strategies":[35],"rely":[36],"on":[37],"atomic":[38],"scale":[39],"understanding":[40,74],"of":[41,90,109,122,127,141,153,156,185,195,204,249],"the":[42,68,87,120,123,128,150,164,168,174,186,196,200,205,255],"biomacromolecule":[44],"traditionally":[45],"derived":[46],"from":[47,263],"X-ray":[48,56,106],"crystallographic":[49],"data":[50,243],"collected":[51,112],"at":[52,94,113],"cryogenic":[53],"temperatures.Conventional":[54],"protein":[55,162],"crystallography":[57],"limited":[59],"possible":[61],"cryo-artifacts":[62],"its":[64],"inability":[65],"to":[66,85,233,253],"locate":[67],"functional":[69],"hydrogen":[70],"atoms":[71],"crucial":[72],"chemistry":[75],"occurring":[76],"in":[77,159,173,193,215,218],"enzyme":[78],"active":[79,129,208],"sites.Neutrons":[80],"are":[81],"ideal":[83],"probe":[84],"observe":[86],"protonation":[88,154,197],"states":[89,155],"ionizable":[91],"amino":[92],"acids":[93],"near-physiological":[95,114],"temperature,":[96],"directly":[97],"determining":[98],"their":[99],"electric":[100,202],"chargescrucial":[101],"information":[102],"design.Our":[105],"crystal":[107,139],"structures":[108,140],"M":[110,145,206,236,250],"temperatures":[115],"brought":[116],"rapid":[117],"insights":[118],"into":[119],"reactivity":[121],"catalytic":[124,169],"cysteine,":[125],"malleability":[126],"site,":[130],"binding":[132,191],"modes":[133],"with":[134,178,217,226],"clinical":[135],"inhibitors.The":[137],"neutron":[138],"ligand-free":[142],"inhibitor-bound":[144],"were":[147],"determined":[148],"allowing":[149],"direct":[151],"observation":[152],"all":[157],"residues":[158],"coronavirus":[161],"first":[165],"time.At":[166],"rest,":[167],"Cys-His":[170],"dyad":[171],"exists":[172],"reactive":[175],"zwitterionic":[176],"state,":[177],"both":[179],"Cys145":[180],"His41":[182],"charged,":[183],"instead":[184],"anticipated":[187],"neutral":[188],"state.Covalent":[189],"inhibitor":[190],"results":[192],"modulation":[194],"states,":[198],"retaining":[199],"overall":[201],"charge":[203],"site":[209],"cavity.In":[210],"addition,":[211],"highthroughput":[212],"virtual":[213],"screening":[214],"conjunction":[216],"vitro":[219],"assays":[220],"identified":[221],"lead":[223],"non-covalent":[224],"compound":[225],"micromolar":[227],"affinity,":[228],"which":[229],"being":[231],"used":[232],"novel":[235],"inhibitors.Our":[238],"research":[239],"providing":[241],"real-time":[242],"atomistic":[245],"discovery":[248],"inhibitors":[252],"combat":[254],"COVID-19":[256],"pandemic":[257],"prepare":[259],"future":[261],"threats":[262],"pathogenic":[264],"coronaviruses.":[265]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-02-13T00:00:00"}